Baczol Expectorant
- Product NDC
- 49523-501
- 11-digit product format
- 495230501
- Labeler code
- 49523
- Product ID
- 49523-501_c612d118-b698-45ab-e053-2a95a90a2948
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- GUAIFENESIN and PHENYLEPHRINE HYDROCHLORIDE
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Lex Inc
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2013-02-04
- Marketing end
- 0000-00-00
- Substance
- GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 200 mg/5mL; mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 49523-501 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 49523-501 | 49523-501-04 | D | Discontinued by firm | 2026-07-31 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49523-501-04 | 2021-07-01 | C162847 | 48780-1 | 9855d018-e2f4-cd31-e053-dbdaa90ab51a | Baczol ® Expectorant |
| 49523-501-04 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e2f4-cd31-e053-dbdaa90ab51a | Baczol ® Expectorant |